https://cancerexplained.org/news/what-patients-should-ask-pediatric-brain-tumor-t-cell-headline Cancer Explained en 2026-07-21T12:00:00.000Z What Patients Should Ask After a Pediatric Brain Tumor T-Cell Headline https://cancerexplained.org/news/what-patients-should-ask-after-adc-headline Cancer Explained en 2026-07-21T12:00:00.000Z What Patients Should Ask After an Antibody-Drug Conjugate Headline https://cancerexplained.org/news/what-changed-this-week-fda-cancer-approvals-july-21-2026 Cancer Explained en 2026-07-21T12:00:00.000Z What Changed This Week in FDA Cancer Approvals: July 21, 2026 https://cancerexplained.org/news/cancer-study-headline-translated-recist-pfs Cancer Explained en 2026-07-21T12:00:00.000Z Cancer Study Headline, Translated: When RECIST and PFS Show Up https://cancerexplained.org/news/cancer-study-headline-translated-cannabis-smoking-risk Cancer Explained en 2026-07-21T12:00:00.000Z Cancer Study Headline, Translated: Cannabis Smoking and Cancer Risk https://cancerexplained.org/news/cancer-myth-news-high-dose-vitamin-c-cure-claims Cancer Explained en 2026-07-21T12:00:00.000Z Cancer Myth in the News: High-Dose Vitamin C Cure Claims https://cancerexplained.org/news/cancer-myth-news-baking-soda-claims-evidence Cancer Explained en 2026-07-21T12:00:00.000Z Cancer Myth in the News: Baking Soda Claims Still Need Evidence https://cancerexplained.org/news/cancer-drug-shortages-this-week-how-to-read-fda-updates Cancer Explained en 2026-07-21T12:00:00.000Z Cancer Drug Shortages This Week: How Patients Can Read FDA Updates https://cancerexplained.org/news/sonrotoclax-mantle-cell-lymphoma-accelerated-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Grants Accelerated Approval to Sonrotoclax for Relapsed Mantle Cell Lymphoma https://cancerexplained.org/news/pembrolizumab-enfortumab-muscle-invasive-bladder-cancer-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Expands Pembrolizumab and Enfortumab Vedotin Around Bladder Surgery https://cancerexplained.org/news/isatuximab-subcutaneous-multiple-myeloma-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Approves Subcutaneous Isatuximab for Multiple Myeloma Indications https://cancerexplained.org/news/gedatolisib-fulvestrant-breast-cancer-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Approves Gedatolisib for Some HR-Positive, HER2-Negative Breast Cancers https://cancerexplained.org/news/capivasertib-pten-prostate-cancer-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Approves Capivasertib for PTEN-Deficient Metastatic Prostate Cancer